newsfilter
← Latest News
Business Wire·

Cyteir Announces Timeline for Voluntarily Delisting from Nasdaq

Cyteir Therapeutics, Inc. ("Cyteir") (NASDAQ:CYT) today announced that it has formally notified The Nasdaq Stock Market ("Nasdaq") of its intent to delist the Company's common stock from the Nasdaq Global Select Market.